misiu143 re sons covid misiu143 Saturday, 08/07/21

New Post Public Reply Private Reply Replies (1) Message Board
crazyjogger925 KenChowder #99084
802
misiu143 re sons covid

misiu143 Saturday, 08/07/21 09:16:36 AM
Re: None 0
Post #
177773
of 177773
I will like to thank everyone who send a good wishes for my son and my family , we very much appreciate that..

So my son is very sick , he went very fast into immune stage of this disease .

In my family we mostly medical profession so we all vacc.
My son , a dentist , had his second Moderna end of January.
My niece had J&J in May , just had covid 12 days ago , and her 3 1/2 child developed 6 days after her , both very good now.

Not with my son , so he went to immune stage of the disease. He was on all the medicine and vitamins possible at home . I spoke yesterday with a doctor in Orlando who is using a lot of Ivermectn with a very good results.
He told me that with Delta , patient must be on double dose with ivermectine he noticed , and then only patients responding.
My son was on 0.20 mg per kg once a day for 5 days , and he said with Delta he just started to use 0.40 mg /kg per day for 5 days.

Anyhow my son was/is very sick , so 3 days ago ambulance took him to the hospital. There were no beds so even in ER they put him with some other patients on small metal chairs to sit , no IV fluid , no glass of water to drink , with his oxygen dropping at moments to 74%.
After 8 hrs of sitting he texted his wife to take him home , and again refused to go to hospital. Yesterday in AM his oxygen drop to 74-80 and only then he said OK.

So I called few hospitals I think are very good , I evaluated where he be the best , and he was admitted there.
Room like in Ritz Carlton , with gorgeous view.
Most important no waiting , immediate help.

They started IV dexamethasone and IV antibiotics. also order remdesivir.
I told my son that there is no reason for this toxic drug as it will not help him at all.
So last night doctor , infectious disease call me from my son room , said that my son is to sick to wait for leronlimab even few days , and I
agreed , we need to give him something , so after talking about all approved drugs we decided on tocilizumab , hoping that he will not develop serious infection since both dexamethasone and tocilizumab are immunosuppressive drugs.

Doctor promised me to call Dr Kelly.

I send an e-mail few days ago to Dr NP telling him about my son and what to do, few minutes later Dr Kelly called me.
So he told me it will not be possible to get leronlimab now since after being approve in Brazil they stopped for now EIND.

Of course I was insisting that they must help my son , so Dr Kelly said , tell his doctor to call me.
In couple of hrs Dr NP also send me an e-mail that he was busy sooner , but asked dr Kelly to call me , and he wished my son the best.

I tried to call Dr Reddy for 3 days , he was organizing the OLE . At least in Florida. But no one pick up the phone and no one called me back..So I think maybe they stopped that too.

We will see how he is doing after the tocilizumab , and hopefully hospital will help with Right To Try to get leronlimab if needed , but all this is not very easy , and this is THE ONLY way to do it now....
Right to Try ..

So the only hope in the future is for leronlimab to be approve soon for something..

Sorry for this long e-mail , but I wanted you to understand that all this is not very easy , and shame on Dr Fauci and FDA , they didn't approve one proper drug during this pandemic imo , and I hope that history will judge them properly.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 5

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming the Future: Insights into MFM Market Growth

Updated Category News Views 185

Exploring the Magnetic Force Microscope Market The magnetic force microscope (MFM) market is on a path of significant expansion, with predictions indicating growth from approximately USD 356 million to over USD 798 million over the next decade. This upward trend highlights a strong compound annual growth rate (CAGR) of 8.4%. The MFM is a vital tool in both industrial and...

Continue Reading
Black Rock Coffee's IPO and Legal Woes Stir Concerns

Updated Category News Views 3

Brewing Trouble: Legal Storm for Black Rock Coffee Amid the aroma of freshly ground beans, Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) finds itself in a bitter brew of legal troubles. The steaming hot news is a securities class action lawsuit challenging the company's disclosures from its IPO. Investors who bought into the hype at $20 a share are now left with a lukewarm...

Continue Reading
Modaxo's Acquisition of SISCOG: Enhancing Rail Technology Solutions

Updated Category News Views 273

Modaxo Expands Its Global Reach with New Acquisition Modaxo Inc. is a forward-thinking organization dedicated to enhancing the movement of people worldwide. Recently, the company has made strides in this mission by acquiring SISCOG - Sistemas Cognitivos, S.A., a well-respected provider of planning and scheduling technology solutions in the rail sector. This acquisition...

Continue Reading
Greater Washington Oral Surgery Opens a New Office in Stafford

Updated Category News Views 177

Greater Washington Oral and Maxillofacial Surgery Opens New Office Greater Washington Oral and Maxillofacial Surgery is excited to announce the launch of its newest office in Stafford, Virginia. This strategic expansion underscores the practice's commitment to providing advanced oral surgical care and enhancing patient access in the region. A Commitment to Community and...

Continue Reading
Goldman Sachs Downgrades Pluxee France: Key Insights and Analysis

Updated Category News Views 115

Goldman Sachs Downgrades Pluxee France In a significant market shift, Goldman Sachs has announced a downgrade for Pluxee France SA (PLX: FP), moving its rating from Neutral to Sell. This decision demonstrates the firm's critical analysis of Pluxee's stock performance and its overall market position. Revised Price Target Alongside the downgrade, Goldman Sachs has adjusted...

Continue Reading